BACKGROUND/ OBJECTIVE: Spontaneous HCV clearance in HCV/HIV-1 coinfected patients is likely to be very rare given the damage to the immune system caused by HIV-1 infection. The search for immune correlates of spontaneous clearance is important for the understanding of pathogenesis as well as for the development of possible new treatment strategies. STUDY DESIGN/ RESULTS: A cohort of HCV/HIV-1 coinfected patients was followed. Plasma HCV viral load was measured and T cell immunity in peripheral blood samples was assessed using multi-color flow cytometry. One HCV/HIV-1 coinfected patient spontaneously became HCV-RNA negative after being positive for several years. This patient displayed a normalized CD4 counts on successful HAART, low level of T cell activation and a high level of T cell function as compared to HCV/HIV-1 coinfected control subjects. CONCLUSIONS: A beneficial immune status including a low level of chronic T cell activation and a high level of T cell function may be one factor that contributes to improved chances of clearance of chronic HCV infection in HIV-1 infected patients.
BACKGROUND/ OBJECTIVE: Spontaneous HCV clearance in HCV/HIV-1 coinfectedpatients is likely to be very rare given the damage to the immune system caused by HIV-1 infection. The search for immune correlates of spontaneous clearance is important for the understanding of pathogenesis as well as for the development of possible new treatment strategies. STUDY DESIGN/ RESULTS: A cohort of HCV/HIV-1 coinfectedpatients was followed. Plasma HCV viral load was measured and T cell immunity in peripheral blood samples was assessed using multi-color flow cytometry. One HCV/HIV-1 coinfectedpatient spontaneously became HCV-RNA negative after being positive for several years. This patient displayed a normalized CD4 counts on successful HAART, low level of T cell activation and a high level of T cell function as compared to HCV/HIV-1 coinfected control subjects. CONCLUSIONS: A beneficial immune status including a low level of chronic T cell activation and a high level of T cell function may be one factor that contributes to improved chances of clearance of chronic HCV infection in HIV-1 infectedpatients.
Authors: Jennifer M Babik; Deborah Cohan; Alexander Monto; Dennis J Hartigan-O'Connor; Joseph M McCune Journal: J Infect Dis Date: 2011-01-15 Impact factor: 5.226
Authors: Anil B Seetharam; Brian B Borg; Vijay Subramanian; William C Chapman; Jeffrey S Crippin; Thalachallour Mohanakumar Journal: Transplantation Date: 2011-12-27 Impact factor: 4.939
Authors: Mario Frias; Antonio Rivero-Juarez; Francisco Tellez; Monserrat Perez-Perez; Angela Camacho; Isabel Machuca; Sandra Lorenzo-Moncada; Pedro Lopez-Lopez; Antonio Rivero Journal: PLoS One Date: 2017-05-04 Impact factor: 3.240
Authors: Adedeji O Majekodunmi; Claire Thorne; Ruslan Malyuta; Alla Volokha; Robin E Callard; Nigel J Klein; Joanna Lewis Journal: Pediatr Infect Dis J Date: 2017-05 Impact factor: 2.129
Authors: Mona M Hassona; Tamer Fouad; Merhan Osama Helmi; Heba Samy Mohammed Ghanem; Heba E Abd Elrhman; Eman Abdelsameea Journal: Clin Exp Hepatol Date: 2021-12-23